ADAC posts record fourth quarter
ADAC Laboratories continues to experience healthy financial growth, thanks to robust performances from all of its businesses. The Milpitas, CA-based nuclear medicine and radiation therapy powerhouse posted a 20% increase in revenue during its record
ADAC Laboratories continues to experience healthy financial growth, thanks to robust performances from all of its businesses. The Milpitas, CA-based nuclear medicine and radiation therapy powerhouse posted a 20% increase in revenue during its record fourth quarter and a 15% revenue increase for its fiscal year.
For the period (end-September), ADAC had record revenues of $86.9 million, compared with the $72.5 million reported in the same period last year. Excluding a one-time restructuring charge, net income was $8.2 million, compared with the $6 million reported last year. With the charge, net income was $3.7 million.
ADAC was also pleased with the progress of its PET business during the quarter. During the period, the company shipped 18 Molecular Coincidence Detection (MCD) units and two C-PET units, compared with 13 MCD units and one C-PET in the prior quarter.
For the fiscal year, ADAC reported revenues of $323.4 million, compared with the $282.3 million reported for the previous fiscal year. Excluding one-time charges, ADAC had net income of $29 million. Including one-time charges, net income for fiscal 1998 was $14.5 million.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Suggests CT-Guided Injections May Restore Sense of Smell in Patients with Long COVID
November 20th 2023Utilizing computed tomography (CT) guidance, researchers have found that performing a minimally invasive anesthetic injection into the stellate ganglia may help address parosmia due to COVID-19, according to study results that will be presented at the annual Radiological Society of North America (RSNA) conference next week.
